Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Psyched Wellness Ltd C.PSYC

Alternate Symbol(s):  PSYCF

Psyched Wellness Ltd. is a Canada-based health supplements company, which is engaged in the distribution of mushroom-derived products and associated consumer packaged goods. The Company is producing and developing a line of Amanita Muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives, such as promote stress relief, relaxation, and assist with restful sleeping. The Company's subsidiaries include Psyched Wellness Corp., and AME Wellness Inc.


CSE:PSYC - Post by User

Psyched Wellness Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(433)
•••
Post by AwareInvestoron Mar 02, 2021 7:24am
191 Views
Post# 32692793

Psyched Wellness Completes Maximum Tolerated Dosage Study Fo

Psyched Wellness Completes Maximum Tolerated Dosage Study Fo
Psyched Wellness this morning issued a brief press release related to the ongoing pre-clinical trial of its muscimol extract, referred to as AME-1. The firm has received the results from its maximum tolerated dosage study, which was conducted through that of KGK Science.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities